From Pain Management to Peptide Optimization: Why Two APRNs Shifted Focus to Metabolic Health

Picture a patient — 54 years old, a retired contractor. He comes in for chronic lower back pain. You look at his chart: type 2 diabetes, hypertension, sleep apnea, a BMI of 38. He's on six medications. He's tried three different pain management protocols. And every single appointment, he asks the same question: "When is this going to get better?"

That patient was in my clinic almost every week for two years. And the honest answer — the one I couldn't quite bring myself to say out loud — was: not until we address the inflammation driving all of this.

That's the conversation that changed the direction of Salt & Serum Wellness. And it's the reason two pain management APRNs are now deeply invested in GLP-1 therapy, peptide optimization, and metabolic health.

The Connection We Kept Seeing at the Bedside

Between the two of us, we've spent years in some of the most demanding clinical environments nursing has to offer. I started in oncology at the University of Miami — a place that teaches you very quickly that the body's systems are not separate. Cancer doesn't just affect one organ. Treatment doesn't just affect one system. Everything is connected.

Chantal spent five years in labor and delivery before transitioning to pain management. L&D gives you an acute, intimate understanding of the body under stress — metabolic, hormonal, inflammatory stress — and how profoundly those systems affect every outcome.

When we both landed in chronic pain management, we found ourselves looking at the same pattern over and over: patients with elevated inflammatory markers, excess adipose tissue, metabolic dysfunction — and pain that simply would not resolve the way it should have, despite our best clinical efforts.

"We weren't just treating pain anymore. We were watching the downstream effects of metabolic disease play out in real time — and realizing that our traditional toolkit wasn't getting to the root of it."

Adipose Tissue Is Not Passive — It's a Source of Chronic Inflammation

This is the part that most patients — and, frankly, many clinicians — still don't fully appreciate. Excess adipose tissue, particularly visceral fat, is metabolically active. It secretes pro-inflammatory cytokines like TNF-α, IL-6, and leptin. It contributes directly to insulin resistance. It feeds the low-grade systemic inflammation that is now understood to underlie not just metabolic disease, but cardiovascular disease, neurodegenerative conditions, and — critically for our patient population — chronic musculoskeletal pain.

When I was treating that 54-year-old contractor, his pain wasn't just a structural problem in his spine. It was, in large part, an inflammatory problem driven by his metabolic state. No amount of trigger point injections or nerve blocks was going to resolve what his inflammatory milieu was perpetuating.

What the Research Was Telling Us

Around 2022 and 2023, the clinical literature on GLP-1 receptor agonists started to shift in a meaningful way. Yes, the weight loss data was impressive — but what caught our attention were the emerging findings on:

• Systemic inflammation: GLP-1 agonists demonstrated direct anti-inflammatory effects independent of weight loss, reducing markers like CRP and IL-6
• Cardiovascular protection: The SUSTAIN and LEADER trials showed significant reductions in major cardiovascular events — not just from weight loss, but from direct cardioprotective mechanisms
• Neuroprotection: Early data suggesting GLP-1 receptors in the brain play a role in neuroinflammation, with potential implications for cognitive health and pain sensitization
• Muscle preservation: When combined with appropriate protocols, newer agents like tirzepatide showed preferential fat loss with relative preservation of lean muscle mass

For two clinicians who spend their days managing the consequences of systemic inflammation, this wasn't just weight loss research. It was a potential paradigm shift in how we address the root causes of the conditions we were treating every day.

Why Peptide Therapy Completed the Picture

GLP-1 therapy addresses the metabolic and inflammatory piece. But what about the patients who aren't significantly overweight — yet still feel the slow decline that comes with aging? The ones with flagging energy, poor recovery, disrupted sleep, and a body composition that seems to be quietly working against them despite doing "everything right"?

That's where peptide optimization entered our clinical thinking.

Peptides like Sermorelin, CJC-1295/Ipamorelin, and BPC-157 work upstream of the symptoms we see in our patients. They support the body's own signaling systems — growth hormone secretion, tissue repair, mitochondrial function, immune regulation. They don't override the body's processes; they restore the communication pathways that age and stress have degraded.

For our patients coming out of pain management — many of whom have been deconditioned, have elevated cortisol from chronic pain, and have lost significant muscle mass — peptides offer a way to rebuild the physiological foundation that makes every other intervention work better.

Why This Practice? Why Now?

We serve a diverse community across Florida. We have a mix of long-term residents managing the chronic conditions that come with age, and a constant influx of visitors who want to feel their best during their time here. We have military families, construction workers, healthcare workers, and retirees — all populations where metabolic health, recovery, and energy matter enormously.

What we didn't have was a clinic offering medically supervised, evidence-based metabolic optimization with the clinical rigor it deserves — delivered in a way that respects people's time and privacy.

That's what Salt & Serum is. It's not a medspa with a GLP-1 pen. It's two APRNs with deep clinical backgrounds, bringing the same standard of care we applied in hospital settings into your home or hotel room — with full lab monitoring, individualized protocols, and the kind of time with each patient that the traditional healthcare system simply doesn't allow.

What This Means for You as a Patient

If you're struggling with weight that isn't responding to diet and exercise, if you have chronic inflammation or pain that seems resistant to treatment, if you're feeling the cognitive and physical effects of aging earlier than you expected — there is a physiologically grounded explanation, and there are evidence-based interventions that work.

The path forward isn't more willpower. It's better biology — addressed at the root, by clinicians who understand the full picture.

That's the practice we built. And it started with a contractor asking a question we couldn't fully answer until we changed our approach entirely.